EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
about
Measures of disability: Arthritis Impact Measurement Scales 2 (AIMS2), Arthritis Impact Measurement Scales 2-Short Form (AIMS2-SF), The Organization for Economic Cooperation and Development (OECD) Long-Term Disability (LTD) Questionnaire, EQ-5D, WorThe comparative burden of mild, moderate and severe fibromyalgia: results from a cross-sectional survey in the United States.A prospective study of lupus and rheumatoid arthritis in relation to deployment in support of iraq and afghanistan: the millennium cohort study.Health-related quality of life in morphoeaThe Comparative Burden of Chronic Widespread Pain and Fibromyalgia in the United States.Identification of a potential fibromyalgia diagnosis using random forest modeling applied to electronic medical records.Fibromyalgia Outcomes Over Time: Results from a Prospective Observational Study in the United States.Association of the lupus low disease activity state (LLDAS) with health-related quality of life in a multinational prospective study.Prevalence of rheumatic and musculoskeletal diseases and their impact on health-related quality of life, physical function and mental health in Portugal: results from EpiReumaPt- a national health survey.The impact of functional constipation on quality of life of middle-aged Black Americans: a prospective case-control study.Patient-Reported Outcomes in Systemic Lupus Erythematosus.Systemic lupus erythematosus and the economic perspective: a systematic literature review and points to considerMeasures of fatigue: Bristol Rheumatoid Arthritis Fatigue Multi-Dimensional Questionnaire (BRAF MDQ), Bristol Rheumatoid Arthritis Fatigue Numerical Rating Scales (BRAF NRS) for severity, effect, and coping, Chalder Fatigue Questionnaire (CFQ), ChecThe humanistic and economic burden of systemic lupus erythematosus : a systematic review.The interaction between autoimmune diseases and fibromyalgia: risk, disease course and management.Illness perceptions and burden of disease in fibromyalgia.The Japanese LupusPRO: A cross-cultural validation of an outcome measure for lupus.Fibromyalgia onset has a high impact on work ability in Australians.Association Between the Single Assessment Numeric Evaluation and the Western Ontario and McMaster Universities Osteoarthritis Index.Culture, science and the changing nature of fibromyalgia.Health-related quality of life and utility: comparison of ankylosing spondylitis, rheumatoid arthritis, and systemic lupus erythematosus patients in Taiwan.Reliability of the SF-36 in Japanese patients with systemic lupus erythematosus and its associations with disease activity and damage: a two-consecutive year prospective study.Musculoskeletal manifestations as determinants of quality of life impairment in patients with systemic lupus erythematosus.Differential impact of systemic lupus erythematosus and rheumatoid arthritis on health-related quality of life.Depression symptoms are associated with key health outcomes in women with fibromyalgia: a cross-sectional study.EQ-5D-derived health utility values in patients undergoing surgery for chronic rhinosinusitis.The clinical burden of generalized osteoarthritis represented by self-reported health-related quality of life and activity limitations: a cross-sectional study.Sexuality of men with fibromyalgia: what are the factors that cause sexual dysfunction?An exploration of patient-reported symptoms in systemic lupus erythematosus and the relationship to health-related quality of life.Qualitative validation of the FACIT-fatigue scale in systemic lupus erythematosus.
P2860
Q26829085-A0F2B582-8DC4-4E37-9221-3CE68574268AQ35231146-AF937C93-E431-46C7-8010-0A42A45553F7Q35579663-F9DED638-71C4-42F3-8072-E2B40008F8CAQ35602574-BC976F02-A096-4B73-80F9-34275CA49B35Q35633313-2022B264-107F-4278-B232-8E879D88BAF7Q35743484-8BC7D0C9-EE7D-4864-AE7E-719788D231C8Q36246938-74AA540D-205B-4EFF-B670-09F815302ADDQ36315477-AE1F61C7-AAE3-4CEF-8253-893D4E2A1C79Q36517265-3BCD7B00-6FF7-42F1-B8DD-F6135F0C33A7Q36610711-0A224B32-B7C4-44C4-A6E8-8210405004B4Q36859757-674D3383-739D-4118-BA3B-1B410C2C0B51Q37021770-FB05F502-1C8F-457F-A647-8945860ABDAFQ38010362-F60350C9-736D-4FDF-B652-572E9261D584Q38074915-54361A78-2EEA-4901-BF9E-05DAF72B05E9Q38156226-3E5E1DB9-6109-4C62-8BC4-19782A831898Q38558687-A6CEAE35-043B-43F2-851F-635392829C77Q39121763-DA868A15-7033-4C48-966F-FDECA2251668Q39724168-18410FA1-8617-4083-BECA-8BFFC6A4BECFQ45062153-C54C7BAE-D9C5-4F1E-B0D3-3774323E00F1Q45817582-1172A0E8-36EB-471A-A8AC-9561C54FF8A4Q47622606-B49F1B35-F2A4-466F-9643-7CF48CBE61C4Q47650435-DC35715D-5CBD-48BE-A1B4-BE671B839A03Q47692440-044A5BFA-544E-4F0E-9ACD-07FE1F0D8858Q47778526-91A3F2E9-0DA8-4E22-85FC-8C06B43AEE82Q47955233-2E072C54-7C90-4F02-916C-20148F2A334FQ48058736-EADD7D1E-7187-455A-9480-5436931F7808Q48063180-BF5A61D1-C35E-4CE0-B682-1DC59C4B8246Q48361227-54442857-80B7-41E7-9F11-612CFC5FB799Q48435382-D5A740A2-8515-4EBA-B2E0-CC6A7F98F747Q50722376-7B965382-0B21-4275-9157-D5BEB2651FEA
P2860
EQ-5D and SF-36 quality of life measures in systemic lupus erythematosus: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, and fibromyalgia.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@en
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@nl
type
label
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@en
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@nl
prefLabel
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@en
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@nl
P2093
P356
P1476
EQ-5D and SF-36 quality of lif ...... c disorders, and fibromyalgia.
@en
P2093
Kaleb Michaud
Robert S Katz
P304
P356
10.3899/JRHEUM.090778
P407
P577
2009-12-23T00:00:00Z